Rohit Bhargava

28PUBLICATIONS
111CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 02, 2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

|Jun 19, 2026
Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations.

|Apr 07, 2026
Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma.

Jagmohan Hooda, Jennifer M Atkinson, Osama Shiraz Shah

|Mar 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Mar 03, 2026
Microglandular adenosis, triple negative breast carcinoma and DNA repair defects.

Mariel Bedell, Edaise M da Silva, Pier Selenica

|Feb 26, 2026
Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.

Jacob A Jerome, Rachel Vanderschelden, Beth Z Clark

Pageof 5

Frequent Collaborators

9 joint publications

Jing Yu

8 joint publications

Jeffrey L Fine

6 joint publications

Steffi Oesterreich

6 joint publications

Adam M Brufsky